Skip to main content

Torley Helen's Form 4 filing

Halozyme Therapeutics, Inc. (HALO) · filed Aug 13, 2025

Accession no.
0001415889-25-021681
Filed
Aug 13, 2025
Trade date
Aug 11-13, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.82M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Torley HelenCIK 0001528185Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 11, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Aug 11, 2025Common StockSSaleDisposed−18,717$63.01−$1,179,358.17735,002Direct
Aug 11, 2025Common StockSSaleDisposed−1,283$63.60−$81,598.8733,719Direct
Aug 12, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Aug 12, 2025Common StockSSaleDisposed−13,042$63.24−$824,776.08740,677Direct
Aug 12, 2025Common StockSSaleDisposed−6,958$64.00−$445,312733,719Direct
Aug 13, 2025Common StockMOption exerciseAcquired+20,000$8.11+$162,200753,719Direct
Aug 13, 2025Common StockSSaleDisposed−14,948$64.15−$958,914.2738,771Direct
Aug 13, 2025Common StockSSaleDisposed−5,052$64.83−$327,521.16733,719Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 11, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200236,569Direct
Aug 12, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200216,569Direct
Aug 13, 2025Common StockMOption exerciseDisposed−20,000$8.11−$162,200196,569Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)